Ekso Bionics Raises Capital via Series B Preferred
TipRanks (Thu, 22-Jan 5:18 PM ET)
Ekso Bionics prices $5.9M private placement
Seeking Alpha News (Wed, 21-Jan 9:06 AM ET)
Ekso Bionics Prices $5.852 million Private Placement
Globe Newswire (Wed, 21-Jan 8:30 AM ET)
PRNewswire (Tue, 13-Jan 1:44 AM ET)
Applied Digital Reports Fiscal Second Quarter 2026 Results
Globe Newswire (Wed, 7-Jan 4:48 PM ET)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--EKSO, FOLD, CWAN, and JHG
PRNewswire (Wed, 7-Jan 1:40 PM ET)
Globe Newswire (Tue, 6-Jan 2:58 PM ET)
PRNewswire (Tue, 6-Jan 10:45 AM ET)
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside
AB Digital Inc (Mon, 5-Jan 2:44 PM ET)
PRNewswire (Mon, 5-Jan 2:22 PM ET)
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Ekso Bionics Holdings trades on the NASDAQ stock market under the symbol EKSO.
As of January 23, 2026, EKSO stock price climbed to $8.71 with 189,026 million shares trading.
EKSO has a beta of 0.43, meaning it tends to be less sensitive to market movements. EKSO has a correlation of 0.00 to the broad based SPY ETF.
EKSO has a market cap of $22.85 million. This is considered a Sub-Micro Cap stock.
Last quarter Ekso Bionics Holdings reported $4 million in Revenue and -$.54 earnings per share. This beat revenue expectation by $169,100 and exceeded earnings estimates by $.43.
In the last 3 years, EKSO traded as high as $703.91 and as low as $2.73.
The top ETF exchange traded funds that EKSO belongs to (by Net Assets): VXF, DFAC.
EKSO has underperformed the market in the last year with a return of -94.0%, while SPY returned +14.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EKSO shares. However, EKSO has outperformed the market in the last 3 month and 2 week periods, returning +78.9% and +9.8%, while SPY returned +2.9% and -0.7%, respectively. This indicates EKSO has been having a stronger performance recently.
EKSO support price is $7.25 and resistance is $8.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EKSO shares will trade within this expected range on the day.
